Please login to the form below
KRAS inhibitor
This page shows the latest KRAS inhibitor news and features for those working in and with pharma, biotech and healthcare.
Amgen’s Lumykras receives conditional marketing authorisation from EC
In May 2021, the US Food and Drug Administration (FDA) granted Lumakras accelerated approval, making Amgen’s drug the first of its kind as a KRAS G12C inhibitor to receive regulatory ... Reese added: "Amgen's landmark scientific discovery allowed
Latest news
-
Green light for Amgen’s KRAS inhibitor in the UK
Amgen’s first-in-class KRAS inhibitor sotorasib has been approved in the UK under a deal between the drug maker and NHS England. ... While KRAS has been a focus of research for nearly 40 years, it has proved one of the most challenging therapeutic
-
Amgen aims for first KRAS inhibitor approval in the US
The company has filed a new drug application (NDA) with the FDA for the investigational KRAS inhibitor, seeking approval for the treatment of patients with KRAS G12C-mutated locally advanced or ... The CodeBreaK 100 study evaluated the KRAS inhibitor in
-
Merck strengthens KRAS stake with Taiho and Astex partnership
Another company looking to crack the KRAS mutation is Amgen, which recently announced some positive data for its pathfinder KRAS inhibitor AMG 510 in KRAS G12C-positive NSCLC. ... Other competitors in the KRAS inhibitor race include Mirati, Boehringer
-
Amgen buys BeiGene stake for $2.7bn to aid push into China
Included in that part of the deal however is Amgen’s much-anticipated KRAS inhibitor AMG 510, and its bispecific antibody pipeline featuring anti-BCMA candidate AMG 420.
-
Amgen reveals more data on KRAS drug
Unveiled an overall disease control rate of 100%. Amgen has revealed more data for its pathfinder KRAS inhibitor AMG 510, building its case for the drug as a treatment for KRAS ... AMG 510 became the first KRAS inhibitor to show activity in a 35-patient
More from news
Approximately 4 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
